International Biotechnology Trust (IBT) 22 aug 2001 Page 2
James Garvey, managing partner of Schroder Ventures Life Sciences Boston office,
Investment Advisor to IBT, commented:
"Discovery Therapeutics has an extensive product pipeline of clinically advanced drug
candidates targeting diversified markets of unmet clinical needs with a combined market
potential of over $4 billion. We believe the company has considerable future growth potential
under the direction of its excellent management team and will add significant value to IBT's
portfolio."
-ENDS-
For further information, please contact:
International Biotechnology Trust
Andrew Barker, Chairman
Tel: 020 7658 3206
Fax. 020 7658 2422
Email: john.spedding@schroders.com
Schroder Ventures Life Sciences
Katja Stout
Tel: 020 7421 7051
Fax: 020 7421 7077
Email:
katja.stout@schroders.com
GCI Financial
Annabel O'Connor
Tel: 020 7398 0800
Fax: 020 7398 0888
Email:
aoconnor@gcifinancial.com
